|
Title
|
|
|
|
Detection and prevalence of carbapenem-resistant Gram-negative bacteria among European laboratories in the COMBACTE network : a COMBACTE LAB-Net survey
|
|
|
Author
|
|
|
|
|
|
|
Abstract
|
|
|
|
| Antimicrobial resistance (AMR) represents a global public health threat that jeopardises the progress medicine has made over the last century. To confront AMR, the Innovative Medicines Initiative (IMI) has supported the development of a large network of hospitals and laboratories in Europe as part of the New Drugs for Bad Bugs (ND4BB) programme and the COMBACTE projects. COMBACTE LAB-Net conducted a pilot survey on distribution and usage of carbapenem resistance detection methods among laboratories in the COMBACTE network in two clinical trials as part of the COMBACTE-CARE project. The survey was sent out to 211 laboratories in 20 European countries between May 2015 and June 2017. Answers were collected from 165 laboratories (78%). Sixty laboratories (36%) reported an outbreak of carbapenem-resistant (CR) Enterobacteriaceae during one of the two years preceding the completion of the survey. High rates of CR Acinetobacter spp. above 50% were reported by 74 laboratories (47%), particularly in the Western Balkan countries where the rates were sometimes higher than 90%. Apart from determining the antimicrobial susceptibility of isolates, laboratories also used various methods, such as Matrix Assisted Laser Desorption Ionization - Time of Flight (MALDI-TOF), Carbapenemase Nordmann-Poirel (Carba NP) test or molecular methods, to detect CR Gram-negative bacteria. The survey resulted in the selection of sites with high resistance rates that successfully recruited many patients in the EURECA observational clinical trial. (c) 2018 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license. (http://creativecommons.org/licenses/by-nc-nd/4.0/) |
|
|
|
Language
|
|
|
|
English
|
|
|
Source (journal)
|
|
|
|
International journal of antimicrobial agents. - Amsterdam
|
|
|
Publication
|
|
|
|
Amsterdam
:
2019
|
|
|
ISSN
|
|
|
|
0924-8579
|
|
|
DOI
|
|
|
|
10.1016/J.IJANTIMICAG.2018.10.013
|
|
|
Volume/pages
|
|
|
|
53
:3
(2019)
, p. 268-274
|
|
|
ISI
|
|
|
|
000459791500008
|
|
|
Pubmed ID
|
|
|
|
30391381
|
|
|
Full text (Publisher's DOI)
|
|
|
|
|
|